Mr. Shah serves as vice president and chief pharmacy officer for Boston Medical Center, where he leads systemwide pharmacy strategy and oversight. A board-certified oncology pharmacist, he brings deep clinical and operational expertise to his role in one of New England’s largest safety-net hospitals. His robust research portfolio spans oncology and non-oncology topics, including biosimilars, Covid-19 therapies, iron deficiency anemia, inflammatory bowel disease and more. Mr. Shah has contributed to advancing digital adherence technologies in lung cancer and has explored novel strategies in treating chemotherapy-induced nausea and cancer-related anorexia and cachexia. His leadership bridges innovation with compassionate care, helping ensure vulnerable populations receive equitable access to life-saving medications.
